Characterization of Arrhythmia-induced Cardiomyopathy

Recruiting Observational Study
Cardiomyopathy Arrhythmia-induced Cardiomyopathy (AiCM)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
2,700 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of the this observational study is to gather clinically available data on patients presenting with a suspicion for arrhythmia-induced cardiomyopathy (AiCM) at the University Hospital Basel.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Prospective part Inclusion Criteria: * Diagnostic or suspicion of AiCM as presence of specified keyword in patient's file or as screened by colleagues of the internal medicine or cardiology clinics * Signed study consent Exclusion Criteria: * Patient's active refusal of the general consent of th…
Contacts

Patrick Badertscher, MD

+41 61 556 58 23

patrick.badertscher@usb.ch

CONTACT

Jeanne du Fay de Lavallaz, MD-PhD

+41 61 328 76 44

jeanne.dufay@usb.ch

CONTACT